Carrier Is Organic Patents (Class 436/528)
-
Patent number: 8129198Abstract: A substrate plate or device adapted for use with biological or chemical assays is disclosed. The device may take the form of a multi-well plate having a three-dimensional, porous layer as part of a support surface within each well for immobilizing probe species. The porous layer is characterized as having a plurality of interconnected voids defined by a matrix of contiguous solid material. A method and its variants are also described.Type: GrantFiled: August 11, 2010Date of Patent: March 6, 2012Assignee: Corning IncorporatedInventors: Ye Fang, Ann M. Ferrie, Yulong Hong, Brian L. Webb
-
Patent number: 8129505Abstract: The present invention provides a process for producing a comb polymer comprising the steps of: a) providing: (i) (w+z) molar equivalents of a monomer; (ii) one molar equivalent of an initiator compound of formula (IX), wherein B3 represents a halogen, B2 represents H or a halogen, Y1 represents a group capable of attaching the residue of an antibody or fragment thereof or capable of being converted into such a group, L represents a linker group, y is 1, 2 or 3, w is at least 1 and z is 0 or greater; (iii) a catalyst capable of catalysing the polymerization of a plurality of the monomers to produce the comb polymer; and b) causing the catalyst to catalyse, in combination with the initiator, the polymerization of a plurality of the monomers (i) to produce the comb polymer.Type: GrantFiled: September 12, 2006Date of Patent: March 6, 2012Assignee: UCB Pharma S.A.Inventors: Timothy John Norman, Benjamin Charles De Candole, Mezher Hussein Ali
-
Patent number: 8119393Abstract: A membrane array used to detect one or more analytes from a small sample of fluid with high sensitivity is provided. The membrane array can be employed in various analytical devices and is especially useful for identifying analytes from whole blood with minimal or negligible background interference.Type: GrantFiled: June 28, 2006Date of Patent: February 21, 2012Assignee: ZBX CorporationInventor: Shi Qinwei
-
Patent number: 8114681Abstract: Methods are provided for detecting and optionally quantitating multiple analytes, including nucleic acid and/or polypeptide analytes, in particle-based assays that can be highly multiplexed. Compositions, systems, and kits related to the methods are also featured.Type: GrantFiled: October 2, 2008Date of Patent: February 14, 2012Assignee: Affymetrix, Inc.Inventors: Jason Martin, Quan Ngoc Nguyen
-
Patent number: 8110407Abstract: Disclosed is a fluorescent semiconductor microparticle assembly comprising at least three kinds of fluorescent semiconductor microparticles with an average particle size of from 1 to 10 nm, having the same chemical composition, a different average particle size and a different emission maximum wavelength in the emission spectra, wherein a standard deviation of emission intensity in each of the at least three kinds of fluorescent semiconductor microparticles is not more than 15%.Type: GrantFiled: August 22, 2007Date of Patent: February 7, 2012Assignee: Konica Minolta Medical & Graphic, Inc.Inventors: Kazuya Tsukada, Hisatake Okada, Hideki Hoshino
-
Patent number: 8110374Abstract: The invention relates to a method and an immunological test kit for predicting the risk of transplant rejection by detecting anti-AT1 receptor auto-antibodies in biological materials of a patient to be examined, e.g. by an immune reaction with the AT1 receptor or functionally analogous peptides or proteins thereof. The invention is also directed to the use of the AT1 receptor or functionally analogous peptides or proteins in order to predict (diagnose) the risk of transplant rejection. Said risk exists if anti-AT1 receptor auto-antibodies can be detected in such biological materials, e.g. in body fluids or tissues.Type: GrantFiled: May 13, 2002Date of Patent: February 7, 2012Assignee: Cell Trend GmbHInventors: Kai Schulze-Forster, Harald Heidecke
-
Publication number: 20120028372Abstract: In one embodiment, a system includes a plurality of metal nanoparticles functionalized with a plurality of organic molecules tethered thereto, wherein the plurality of organic molecules preferentially interact with one or more analytes when placed in proximity therewith. According to another embodiment, a method for detecting analytes includes contacting a fluid having one or more analytes of interest therein with a plurality of metal nanoparticles, each metal nanoparticle having a plurality of organic molecules tethered thereto, and detecting Raman scattering from an analyte of interest from the fluid, the analyte interacting with one or more of the plurality of organic molecules. In another embodiment, a method includes chemically modifying a plurality of cyclodextrin molecules at a primary hydroxyl moiety to create a chemical handle, and tethering the plurality of cyclodextrin molecules to a metal nanoparticle using the chemical handle. Other systems and methods for detecting analytes are also described.Type: ApplicationFiled: July 27, 2010Publication date: February 2, 2012Inventors: Thomas Yong-Jin Han, Carlos A. Valdez, Tammy Y. Olson, Sung Ho Kim, Joe H. Satcher, JR.
-
Patent number: 8105821Abstract: Silanation compositions containing a mixture of two or more silanation reagents, where at least one silanation reagent includes a functional group capable of supporting polymer synthesis and at least one silanation reagent includes no functional group capable of supporting polymer synthesis are useful in modulating the active site density and hydrolytic stability of a surface. These compositions are particularly useful in silanating a surface prior to preparation of a polymer array and provide for increased hybridization results.Type: GrantFiled: January 23, 2009Date of Patent: January 31, 2012Assignee: Affymetrix, Inc.Inventors: Glenn H. McGall, Robert G. Kuimelis
-
Patent number: 8101425Abstract: The invention provides devices, test kits and methods for removing target agents from a sample. The device contains one or more porous matrices having pore sizes larger than 10 ?m, and a plurality of particles impregnated therein. The target agents attach the device and are removed from the sample.Type: GrantFiled: June 9, 2005Date of Patent: January 24, 2012Assignee: Pathogen Removal and Diagnostic Technologies Inc.Inventor: Ruben G. Carbonell
-
Patent number: 8088630Abstract: Embodiments of the present invention relate to devices and methods for detecting cellular products using detection particles having product-specific detection reagents and having a characteristic spectral feature. In particular, devices and methods are provided for measuring secreted cellular products including cytokines. Detection substrates, include microwells having product-specific capture reagents thereon or comprising hydrophobic membranes are described having greater capability to detect products from individual cells in a mixture of heterogeneous cells. With the use of multiple detection particles, multiple cellular products can be detected in a single well. Additionally, using the inherent spectral properties of detection particles, no enzymatic reactions are needed to visualize a secreted product, thereby increasing the sensitivity, reproducibility and ease of use.Type: GrantFiled: September 25, 2009Date of Patent: January 3, 2012Inventors: Paul V. Lehmann, Alexey Y. Karulin, Thomas Oliver Kleen
-
Patent number: 8076163Abstract: A plurality of particles of from about 5 nm to 100 ?m possessing predetermined isoelectric points in the pH range of from about 2.5 to 11 is used in a method of detection of a plurality of analytes, wherein the isoelectric particles of each isoelectric point further contain as label and a member of a binding pair capable of interacting with a selected analyte. The particles that form specific binding pairs are recovered and separated by isoelectric focusing followed by the detection of the labels associated with the particles. A flow cytometer may be used as a detector of the isoelectric particles.Type: GrantFiled: July 21, 2008Date of Patent: December 13, 2011Assignee: Gentius, IncorporatedInventor: Branko Kozulic
-
Patent number: 8067053Abstract: Disclosed is a method for selective chemical binding and immobilization of macromolecules on solid supports in conjunction with self-assembled monolayer (SAM) surfaces. Immobilization involves selective binding of peptides and other macromolecules to SAM surfaces using reactive landing (RL) of mass-selected, gas phase ions. SAM surfaces provide a simple and convenient platform for tailoring chemical properties of a variety of substrates. The invention finds applications in biochemistry ranging from characterization of molecular recognition events at the amino acid level and identification of biologically active motifs in proteins, to development of novel biosensors and substrates for stimulated protein and cell adhesion.Type: GrantFiled: May 9, 2008Date of Patent: November 29, 2011Assignee: Battelle Memorial InstituteInventors: Julia Laskin, Peng Wang
-
Patent number: 8053246Abstract: To provide a method for enhancing analysis sensitivity of bio-related molecules in mass spectrometry. To provide a method for rapidly and conveniently analyzing biological acid molecules using the method of enhanced analysis sensitivity in mass spectrometry. A method of preparing a bio-related molecule to be subjected to mass spectrometry, in which at least a part of acid group(s) is esterified, comprising reacting a bio-related molecule comprising an acid group(s) with a triazene compound to esterify at least a part of said acid group(s). A method of analyzing bio-related molecules comprising reacting a bio-related molecule comprising an acid group(s) with a triazene compound to esterify said acid group(s), and then subjecting said bio-related molecule having an esterified acid group(s) to mass spectrometry.Type: GrantFiled: February 22, 2007Date of Patent: November 8, 2011Assignee: National University Corporation Hokkaido UniversityInventors: Shin-Ichiro Nishimura, Yoshiaki Miura
-
Patent number: 8048376Abstract: An apparatus and a related method for performing particle agglutination reactions in at least one disposable probe tip are disclosed. The at least one probe tip includes a sample cavity for sample acquisition, at least one flanking cavity for the capture of particles by centrifugation or other means, a transition zone for the mixing of the sample with reagents for agglutination and a detection zone for the optical detection of particle agglutination. A mechanism may be attached to the probe tip for the controlled movement of fluids through the internal volume of the probe tip. The probe tip is particularly useful for the automation of high-throughput agglutination-type assays.Type: GrantFiled: November 24, 2010Date of Patent: November 1, 2011Assignee: Ortho-Clinical Diagnostics, Inc.Inventors: Zhong Ding, Amy M. Wilson-Colley
-
Patent number: 8039273Abstract: Ligand Drug conjugate compounds comprising a ?-glucuronide-based linker and methods of using such compounds are provided.Type: GrantFiled: July 18, 2006Date of Patent: October 18, 2011Assignee: Seattle Genetics, Inc.Inventor: Scott Jeffrey
-
Patent number: 8039268Abstract: An immunochromatoassay method that allows high detection sensitivity measurement. The method including the steps of: permeating an analyte solution that includes a visibly labeled second binding substance that specifically binds to a detection target substance into a test area of a chromatography medium provided with a first binding substance that specifically binds to the detection target substance, simultaneously with or after the permeation of the analyte solution into the test area, permeating a visual recognition aid solution into the chromatograph medium, the solution having a refractive index whose refractive index difference ?n from that of the chromatograph medium is ?0.1??n?0.1, and visually observing the test area while the visual recognition aid solution is permeated in the test area.Type: GrantFiled: April 13, 2009Date of Patent: October 18, 2011Assignee: FUJIFILM CorporationInventor: Hisashi Ohtsuka
-
Patent number: 8034397Abstract: Hollow particles for use in various types of assay devices are provided. Due to their hollow or voided structure, the particles may exhibit a variety of beneficial properties. For instance, hollow particles are generally lightweight, and thus, relatively inexpensive in comparison to other types of particles. Hollow particles may also form a stable system without requiring refrigeration or rotation. In addition, hollow particles may possess enhanced light diffraction capabilities, which may be particularly beneficial in certain types of assay devices, e.g., diffraction-based assay devices.Type: GrantFiled: September 28, 2010Date of Patent: October 11, 2011Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Kaiyuan Yang, Ning Wei, Rosann Kaylor, Chibueze Obinna Chidebelu-Eze, Zdravko Savov Atanassov
-
Patent number: 8030095Abstract: A gel microdrop composition is provided. In certain embodiments, the gel microdrop composition contains a polymer matrix, an effector particle that releases an effector molecule into the polymer matrix, a first reporter particle that emits a first optically detectable signal and a second reporter particle that emits a second optically detectable signal that is distinguishable from the first optically detectable signal, where the effector particle and said first and second reporter particles are encapsulated by the polymer matrix. Methods of screening that employ the gel microdrop composition and methods of making the gel microdrop composition are also disclosed.Type: GrantFiled: March 2, 2009Date of Patent: October 4, 2011Assignee: Crystal Bioscience Inc.Inventor: William Don Harriman
-
Patent number: 8030069Abstract: The subject invention provides new materials and methods for the efficient isolation and purification of stem cells. Specifically, conductive immunopolymers with stem cell specific antibodies can be used to remove stem cells from biological fluids.Type: GrantFiled: April 24, 2009Date of Patent: October 4, 2011Assignee: Morphogenesis, Inc.Inventors: Michael J. P. Lawman, Patricia D. Lawman
-
Publication number: 20110236884Abstract: The present invention relates to methods, compositions and kits for affinity isolation, affinity purification and affinity assay based on microbubbles coated with an affinity molecule. Particularly, the invention provides protein microbubbles coated with an affinity molecule. In addition, the invention provides glass microbubbles coated with an affinity molecule. Methods of using the microbubbles of the invention for isolating analytes and cells are specifically provided.Type: ApplicationFiled: May 31, 2011Publication date: September 29, 2011Inventors: Edward Jablonski, Thomas Adams
-
Patent number: 8017174Abstract: A system and method for recognition of images may include the use of alignment markers. The image recognized may be a pattern from an array, a character, a number, a shape, and/or irregular shapes. The pattern may be formed by elements in an array such as an identification marking and/or a sensor array. More particularly, the system and method relate to discriminating between images by accounting for the orientation of the image. The size and/or location of alignment markers may provide information about the orientation of an image. Information about the orientation of an image may reduce false recognitions. The system and method of image recognition may be used with identification markings, biosensors, micro-fluidic arrays, and/or optical character recognition systems.Type: GrantFiled: October 31, 2007Date of Patent: September 13, 2011Assignee: Board of Regents The University of Texas SystemInventors: Jason E. Meiring, Timothy B. Michaelson, C. Grant Willson
-
Patent number: 8018595Abstract: Provided is an apparatus for detecting bio materials and a method for detecting bio materials by using the apparatus. The apparatus includes a bio material reacting unit, an optical source unit, and a detecting unit. The bio material reacting unit includes bio sensing materials immobilized on gold nanoparticles. The optical source unit emits light toward the bio material reacting unit. The detecting unit measures variations of surface absorbance of the gold nanoparticles by detecting light transmitted through the bio material reacting unit before and after a bio material is bound to the bio sensing materials.Type: GrantFiled: March 18, 2009Date of Patent: September 13, 2011Assignee: Electronics and Telecommunications Research InstituteInventors: Chul Huh, Kyung Hyun Kim, Hyunsung Ko, Wanjoong Kim, Gun Yong Sung, Seon-Hee Park, Bong-Kyu Kim
-
Patent number: 8008032Abstract: Method of enriching specific cells from cellular samples are disclosed, comprising contacting in solution a cellular sample with affinity-tagged ligands (ATLs) each comprising a first ligand linked to an affinity tag, wherein the ligand selectively binds a cellular marker of the rare cells and the affinity tag can be selectively captured by a capture moiety, wherein the affinity tags do not comprise a magnetic particle; and flowing the sample through a microfluidic device comprising the capture moiety to selectively retain ATL-bound cells. Methods for enriching circulating tumor cells, and devices for enriching specific cells from cellular samples are also disclosed.Type: GrantFiled: February 25, 2008Date of Patent: August 30, 2011Assignee: Cellective DX CorporationInventors: Allyn Forsyth, Helen Barnes
-
Publication number: 20110200986Abstract: There is provided a method, an in vitro method and a detection system for detecting the presence of at least one biological molecule in at least one sample. The method can include, for example, providing a sample and/or a binding agent to a contact portion of a surface by way of at least one microfluidic channel; disposing a liquid crystal at the contact portion; determining whether the orientation of the liquid crystal changes after the sample contacts the binding agent, indicating the presence of the biological molecule; and determining length of bright region of the liquid crystal and/or change in interference color of said liquid crystal, and consequently indicating the quantity of said biological molecule. Also disclosed are methods of detecting biological molecules using at least one 4?-pentyl-biphenyl-4-R, where R may be at least one functional group selected from carboxylic acid, amine, aldehyde, and oligopeptide.Type: ApplicationFiled: October 6, 2009Publication date: August 18, 2011Applicant: NATIONAL UNIVERSITY OF SINGAPOREInventors: Kun-Lin Yang, Changying Xue, Saif A. Khan, Xinyan Bi
-
Patent number: 7998696Abstract: A method and kit for assaying a cell sample for the presence of at least a threshold number of cells of a given type are disclosed. The kit includes an assay device having a sample chamber for receiving the cell sample and an elongate collection chamber containing a selected-density and/or viscosity medium and having along its length, a plurality of cell-collection regions, and particles which are capable of specific attachment to cells of the selected cell type, and which are effective, when attached to the cells, to increase the density or magnetic susceptibility of the cells. In operation, particle-bound cells and particles in the cell sample are drawn through the elongate collection chamber under the influence of a gravitational or selected centrifugal or magnetic-field force until the particle-bound cells and particles completely fill successive cell-collection regions in the collection chamber.Type: GrantFiled: December 5, 2008Date of Patent: August 16, 2011Assignee: Zyomyx, Inc.Inventors: Frank Zaugg, Renee Tobias, Silvia McManus-Munoz, Peter Kernen, Laurence Ruiz-Taylor, Peter Wagner
-
Patent number: 7998412Abstract: An ophthalmic device which comprises a holographic element comprising a medium comprising a phenylboronic acid group and, disposed therein, a hologram, wherein an optical characteristic of the element changes as a result of a variation of a physical property of the medium, and wherein the variation arises as a result of interaction between the medium and an analyte present in an ocular fluid.Type: GrantFiled: February 16, 2008Date of Patent: August 16, 2011Assignee: Smart Holograms LimitedInventors: Barry Burles, Roger Bradley Millington, Christopher Robin Lowe, Satyamoorthy Kabilan, Jeffrey Blyth
-
Patent number: 7998756Abstract: Use of a latex of perfluorinated polymers having particles with an average diameter between 5 and 200 nm for determining the binding constant of two interacting molecular species by Laser Light Scattering (LLS), said polymeric particles comprising on the surface an amphiphilic non ionic surfactant, the same or a different surfactant ended with a receptor and a ligand interacting with the receptor.Type: GrantFiled: September 16, 2005Date of Patent: August 16, 2011Assignee: Solvay Solexis S.p.A.Inventor: Mattia Bassi
-
Patent number: 7998726Abstract: The aim of the present invention is to provide a method for attaching a protein to a conductive polymer, that can be used in particular for producing a sensor or a multisensor, for example a biochip. This aim, and also others, are achieved, in accordance with the invention, by means of a method for attaching a protein to a pyrrole polymer, comprising the following steps: coupling of the protein to be attached with pyrrole so as to obtain a first solution of a protein-pyrrole coupling compound, preparation of a second solution of pyrrole not containing the protein, mixing of said first solution with said second solution so as to obtain an electropolymerization solution, electropolymerization of the pyrrole and of the protein coupled to the pyrrole on a conductive support using said electropolymerization solution.Type: GrantFiled: November 20, 2003Date of Patent: August 16, 2011Assignees: Commissariat a l'Energie Atomique, Centre National de la Recherche ScientifiqueInventors: Andre Roget, Thierry Livache, Yves Levy
-
Patent number: 7985600Abstract: Use of flat surfaces comprising perfluorinated polymers in the determination of the binding constant of two interacting molecular species by using measurements of reflected light intensity, said surface comprising at least one molecule with the receptor function adsorbed or immobilized on said surface, and at least one ligand which interacts with the receptor.Type: GrantFiled: March 14, 2007Date of Patent: July 26, 2011Assignee: Solvay Solexis S.p.A.Inventor: Mattia Bassi
-
Patent number: 7985601Abstract: The present invention provides a class of semi-interpenetrating polymeric networks that include a linear polymer molecule functionalized with a bioactive moiety. The linear polymer is physically entangled within a matrix based upon a thermo-responsive polymer. The bioactive moiety is, e.g., a therapeutic moiety or a moiety that enhances the interaction of a cell with the polymer network. The polymer networks of the invention are flowable at room temperature, becoming solid or semi-solid at elevated temperatures (e.g., body temperature). The polymer networks are of use as drug delivery vehicles and as matrices for tissue engineering.Type: GrantFiled: March 10, 2003Date of Patent: July 26, 2011Assignees: The Regents of the University of California, Northwestern UniversityInventors: Kevin E. Healy, Ranee A. Stile
-
Patent number: 7981694Abstract: The invention is a method for the isolation of molecules of interest using tubes in which at least a portion of the inner walls of the tube are coated with microbeads that are coated with a capture reagent to bind the molecule of interest. The microbeads may be glass or polymer beads. The invention is a method and apparatus for preparation of the tubes for use in the method of the invention. The invention is a method for determining ratios of guanine nucleotides bound to guanine-nucleotide binding proteins.Type: GrantFiled: January 28, 2004Date of Patent: July 19, 2011Assignee: The Regents of the University of CaliforniaInventors: Gerry R. Boss, Stephen B. Jones, Jeffrey C. Chen, Friederike von Lintig, Stephanie Hoffman, Adam Kimmerly, Joann Luu, Matthew Christopher Mycroft
-
Patent number: 7981665Abstract: Described herein are supports for assaying an analyte and methods of making and using thereof.Type: GrantFiled: January 22, 2009Date of Patent: July 19, 2011Assignee: Corning IncorporatedInventors: Anthony G. Frutos, David Henry
-
Patent number: 7972827Abstract: Described herein is a method for the attachment of proteins to any solid support with control over the orientation of the attachment. The method is extremely efficient, not requiring the previous purification of the protein to be attached, and can be activated by UV-light. Spatially addressable arrays of multiple protein components can be generated by using standard photolithographic techniques.Type: GrantFiled: February 18, 2010Date of Patent: July 5, 2011Assignee: Lawrence Livermore National Security, LLCInventors: Julio A. Camarero, James J. DeYoreo, Youngeun Kwon
-
Patent number: 7968349Abstract: The present invention relates to a process for the detection of an analyte in a sample, comprising a) bringing the sample into contact with a first ligand which binds specifically to the analyte and which is immobilized on a substrate, and b) prior to or subsequent to step (a), bringing the sample into contact with a second ligand which binds specifically to the analyte and which includes a label: wherein the substrate comprises a holographic sensor comprising a support medium having a hologram disposed therein or thereon and the label causes an optical property of the sensor to change by interaction of the sensor with the label or, following the additional step of contacting the substrate with a reagent, by interaction of the sensor with a species produced by reaction of the label with the reagent, thereby indicating the presence of bound analyte.Type: GrantFiled: August 23, 2006Date of Patent: June 28, 2011Assignee: Cambridge Enterprise LimitedInventors: Christopher Robin Lowe, Alexander James Marshall
-
Patent number: 7964370Abstract: An analytical strip and a detecting method using the analytical strip are provided. The analytical strip includes a substrate having a channel thereon. The channel has a first region, a second region and a third region, which are connected sequentially. A first antibody is localized in the first region. A saccharide and a peroxidase are localized in the first or second region. A second antibody for recognizing a different epitope of an identical antigen with the first antibody is immobilized in the second region. An optical substrate and a substrate reagent including a saccharide oxidase are localized in the third region.Type: GrantFiled: October 17, 2008Date of Patent: June 21, 2011Assignee: Actherm IncInventors: Yi-Jen Wu, Wen-Pin Hsieh, Chih-Wei Hsieh
-
Patent number: 7964415Abstract: Water soluble, polyethylenimine polymers, conjugated to one or more active moiety are taught. Also taught are methods of making same, kits comprising same, and use of same in immunoassay systems.Type: GrantFiled: April 26, 2006Date of Patent: June 21, 2011Assignee: CardioGenics Inc.Inventors: Pavel Zhelev, Amer Alagic, Yahia A. Gawad
-
Patent number: 7955791Abstract: A test strip and method for detecting an analyte present in a sample.Type: GrantFiled: April 20, 2009Date of Patent: June 7, 2011Assignee: Relia Diagnostic SystemsInventors: Robert K. Dinello, Alan J. Polito, Stella Quan
-
Patent number: 7955867Abstract: In the present invention cells are placed in a multiwell plate and grown. When the assay is to be performed, one uses gravity to wash away any unbound ligands rather than vacuum or centrifugation. The cells are then examined to detect the bound ligand. To perform the washing step(s) the plate is placed into a carrier plate having open wells in register with the wells of the filter plate or one may use a wicking device or an underdrain attached to the bottom of the filter plate. Sufficient wash liquid is added to allow for filtration by the effect of gravity to occur. Cells are retained within the wells at a rate of 4 times that of other rapid methods.Type: GrantFiled: January 18, 2008Date of Patent: June 7, 2011Assignee: Millipore CorporationInventor: Jun Y. Park
-
Patent number: 7943395Abstract: A flow-through assay device for detecting the presence or quantity of an analyte residing in a test sample is provided. The device utilizes multiple detection zones, one of which is premised on “competitive” binding of the analyte and the other is premised on “sandwich” binding of the analyte. The present inventors believe that the combination of these zones may enable the detection of an analyte over extended concentration ranges.Type: GrantFiled: November 21, 2003Date of Patent: May 17, 2011Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Ning Wei, Rameshbabu Boga
-
Patent number: 7943368Abstract: Methods for reducing time to result in blood bank diagnostic testing with an agitation device and a low ionic strength solution are disclosed. Specifically provided are methods for reducing incubation time for antigen-antibody reactions in an immunohematologic assay by subjecting the assay reactants to incubation with agitation and optionally additionally a low ionic strength diluent.Type: GrantFiled: May 4, 2010Date of Patent: May 17, 2011Assignee: Micro Typing Systems, Inc.Inventors: Harry Malyska, Paula Howard
-
Patent number: 7939283Abstract: Assays, such as immunoassays, and related articles are disclosed.Type: GrantFiled: July 12, 2002Date of Patent: May 10, 2011Assignee: Fisher Scientific Company L.L.C.Inventors: Teresa Chan, Joseph F. Lawlor, Gordon C. Siek, Arleen Chase, Joseph D. Musto
-
Patent number: 7935538Abstract: A lateral flow assay device for detecting the presence or quantity of an analyte in a test sample is provided. The device comprises a chromatographic medium that defines a detection zone, wherein a crosslinked network is non-diffusively immobilized within the detection zone. The crosslinked network contains a small molecule indicator that is configured to undergo a detectable color change in the presence of the analyte.Type: GrantFiled: December 15, 2006Date of Patent: May 3, 2011Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Xuedong Song, Curtis Sayre, Shawn R. Feaster, Julie Villanueva
-
Patent number: 7927880Abstract: The invention provides methods for early diagnosis or detection of acute coronary syndrome and prediction of adverse cardiac events on the basis of elevations of catalytic iron in biological fluid of a human subject. An embodiment of the invention provides a method for early detection of acute coronary syndrome (ACS) in a human subject at the time of presentation of the chest pain. The method includes analyzing a test sample of the biological fluid for amount of catalytic iron and detecting acute coronary syndrome in the human subject.Type: GrantFiled: May 21, 2008Date of Patent: April 19, 2011Inventors: Mohan Rajapurkar, Suhas Lele, Sudhir Shah
-
Patent number: 7927789Abstract: The invention relates to compositions and methods for detecting biomolecular interactions. The detection can occur without the use of labels and can be done in a high-throughput manner. The invention further relates to self-referencing colorimetric resonant optical biosensors and optical devices.Type: GrantFiled: April 20, 2009Date of Patent: April 19, 2011Assignee: SRU Biosystems, Inc.Inventors: Cheryl Baird, Brian T. Cunningham, Peter Li
-
Patent number: 7923054Abstract: A substrate comprising a microporous microstructure, an interlayer over at least a portion of the microstructure and a functional layer attached to the interlayer, the functional layer having functional sites with a density of at least 50 nanomoles/cm2.Type: GrantFiled: April 19, 2006Date of Patent: April 12, 2011Assignee: Gore Enterprise Holdings, Inc.Inventors: Anit Dutta, Heidi Flannery, William P. Mortimer, Jr.
-
Patent number: 7923211Abstract: A method to determine specificity of ligand binding includes comparing a solid phase carrier first extract obtained by pre-treating a sample with a ligand-immobilized solid phase carrier and a solid phase carrier second extract obtained by treating the pretreated sample again with a ligand-immobilized solid phase carrier in terms of the proteins contained therein, and identifying a protein whose content is remarkably decreased in the second extract compared to the first extract, in order to solve 1) the problem of the solubility of subject ligand, 2) the problem of the non-specific protein-denaturing effect of the subject ligand added, and the like, in antagonism experiments in target search using an affinity resin.Type: GrantFiled: August 19, 2009Date of Patent: April 12, 2011Assignee: Reverse Proteomics Research Institute Co., Ltd.Inventors: Akito Tanaka, Akira Yamazaki
-
Patent number: 7910301Abstract: The small molecule profiles of cells are compared to identify small molecules which are modulated in altered states. Cellular small molecule libraries, methods of identifying tissue sources, methods for treating genetic and non-genetic diseases, and methods for predicting the efficacy of drugs are also discussed.Type: GrantFiled: March 27, 2007Date of Patent: March 22, 2011Assignees: Metabolon, Inc., Cornell Research Foundation, Inc.Inventors: Rima Kaddurah-Daouk, Bruce S. Kristal
-
Publication number: 20110045608Abstract: Novel conjugates and immunogens derived from imatinib and monoclonal antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of imatinib or its pharmacologically active salts in biological fluids.Type: ApplicationFiled: August 19, 2009Publication date: February 24, 2011Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Alexander Volkov
-
Patent number: 7892774Abstract: The invention relates to a diagnostic method for detecting susceptibility to delivery, and to a test kit for this purpose. A low, but higher than baseline level concentration of Insulin-like Growth Factor Binding Protein 1 (IGFBP-1), which is due to leakage from decidual cells, is detected by an immunological assay in a vaginal secretion sample.Type: GrantFiled: December 29, 2009Date of Patent: February 22, 2011Assignee: Oy Medix Biochemica ABInventor: Eeva-Marja Rutanen
-
Patent number: 7888133Abstract: The invention relates to method of detecting autoantibodies from patients suffering from rheumatoid arthritis. To this end, according to the invention, at least two peptide units are used of which at least one peptide unit comprises a part not derived from (pro)filaggrin, fibrin, fibrinogen, vimentin, cytokeratin 1 and cytokeratin 9, and which peptide unit comprises the motif XG, and a peptide unit comprising the motif XnonG, wherein X is a citrulline or an analogue thereof, and nonG is an amino acid other than glycine.Type: GrantFiled: December 11, 2002Date of Patent: February 15, 2011Assignee: Stichting Voor De Technische WetenschappenInventors: Waltherus Jacobus Wilhelmus Van Venrooij, Jan Wouter Drijfhout, Martinus Adrianus Maria Van Boekel, Gerardus Jozef Maria Pruijn